Skip to content
Search

Latest Stories

AIMP warns of ‘tsunami of further pharmacy closures’

AIMP warns of ‘tsunami of further pharmacy closures’

Fight4Pharmacies campaign launched, calling on the government to invest in community pharmacy.

The Association of Independent Multiple Pharmacies (AIMp) has raised concerns over the mounting pressure faced by general practitioners (GPs) in England due to the loss of community pharmacies.


According to the organisation, more than 400 local chemists have closed in five years, leading to 2.5 million more GP appointments and exacerbating the strain on already stretched GP surgeries.

AIMp CEO Dr Leyla Hannbeck pointed to a combination of “chronic underfunding, medicine supply challenges and a dysfunctional reimbursement system” as the catalyst behind the alarming surge in pharmacy closures.

She warned that if this trend persists, it could trigger a “tsunami of further pharmacy closures” across the country, as quoted by The Mirror.

Additionally, Dr. Leyla highlighted that the sector is grappling with a £1.2 billion funding deficit, resulting in pharmacies “falling into debt” and uncertainty about their sustainability.

According to AIMP, the previous five-year funding agreement (set in 2019 at £2.6 billion annually) failed to consider inflation. Consequently, this has resulted in a year-on-year real-term funding cut, leading to a £1.2 billion shortfall.

On Wednesday, AIMp launched its Fight4Pharmacies campaign, calling on the government to invest in community pharmacy.

‘No funds available to fund community pharmacies’

During a recent meeting with pharmacy minister Andrea Leadsom, Dr Hannbeck and AIMp board member Has Modi discussed the current challenges in the sector and offered solutions on how the community pharmacy network could support the NHS.

They highlighted to the minister that pharmacies could play a vital role in the prevention agenda and management of long-term conditions, but the current funding shortfall has left has left numerous pharmacies grappling to stay afloat.

Additionally, the minister was informed that the sector “is consistently seeing medicines prices go up and pharmacies are left out of pocket because the concessions are not granted on time and the system is flawed.”

However, Leadsom responded that “there are no funds available to fund community pharmacies”.

Referring to reports received by the government indicating that pharmacies like Boots and other large multiples are “making money,” she suggested that independents should also “strive to increase their retail offering and provide more private services.”

AIMp then outlined to the minister that “not all pharmacies can be compared to Boots.” They elaborated that over 90 per cent of the activities in independent pharmacies are NHS activities and many of these chemists are based in “areas of deprivation and health and inequality where the public cannot pay for private services or goods and expect NHS to cover the costs.”

However, the minister acknowledged that the price fluctuations have left contractors out of pocket and that this needs to be addressed on priority.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less